Clinical and Experimental Studies of Cysteine Cathepsins and Their Inhibitors in Human Brain Tumors

Mork S.J. , Wester K. Malignant gliomas: histological features, invasion and relation to clinical symptoms. In: Mikkelsen T. , Bjerkvig R. , Kaerum O.D. , Rosenblum M.L. , eds. Brain tumor invasion. New York: Wiley-Liss, Inc., 1998; 89–110.

Pilkington G.J. Tumor cell migration in the central nervous system. Brain Pathol 1994; 4: 157–66.

Schmitt M. , Janicke F. , Graeff H. : Tumor-associated proteases. Fibrinolysis 1992; 6: 3–26.

Lah T.T. , Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 1998; 379: 125–30.

Lah T.T. , Kos J. , Blejec A. , Frkovič-Georgio S. , Golouh R. , Vrhovec I. , Turk V. The expression of lysosomal proteinases and their inhibitors in breast cancer: Possible relationship to prognosis of the disease. Pathol Oncol Res 1997; 3: 89–98.

Levičar N. , Kos J. , Blejec A. Comparison of cysteine and serine proteinases and their inhibitors as prognostic factors in breast carcinoma. (submitted).

Knoch H. , Werle B. , Ebert W. , Spiess E. Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int J Oncol 1994; 5: 77–85.

Calkins C.C. , Sloane B.F. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe-Sayler, 1995; 376: 71–80.

Strojnik T. , Kos J. , Židanik B. , Golouh R. , Lah T. Cathep-sin B immunohistochemical staining in tumor and endothelial cells as a new prognostic factor for survival in patients with brain tumors. Clin Cancer Res 1999; 5: 559–67.

Frosch B.A. , Sloane B. The role of proteolytic enzymes in brain tumor infiltration. In: Mikkelsen T. , Bjerkvig R. , Kaerum O.D. , Rosenblum M.L. , eds. Brain tumor invasion. New York: Wiley -Liss, Inc., 1998; 275–300.

Liotta L.A. , Steeg P.S. , Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64: 327–36.

Sivaparvathi M. , McCutcheon I. , Sawaya R. , Nicolson G.L. , Rao J.S. Expression of cysteine protease inhibitors in human gliomas and meningiomas. Clin Exp Metastasis 1996; 14: 344–50.

Paulus W. Brain extracellular matrix, adhesion molecules and glioma invasion. In: Mikkelsen T. , Bjerkvig R. , Kaerum O.D. , Rosenblum M.L. , eds. Brain tumor invasion. New York: Wiley-Liss, Inc., 1998; 301–22.

Lah T.T. , Buck M. , Honn V.K. Degradation of laminin by human tumor cathepsin B. Clin Exp Metastasis 1989; 7: 461–8.

Buck M.R. , Karusti D.G. , Day A.N. , Honn K.V. , Sloane B.F. Degradation of extracellular matrix proteins by human cathepsin B from normal and tumor tissues. Biochem J 1992; 282: 273–8.

Kos J. , Šmid A. , Krašovec M. Lysosomal proteases Cats D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Biol Chem Hoppe-Seyler 1995; 378: 401–5.

Cox D.R. Regression models and life tables. J R Stat Soc, 1972; 34: 187–220.